Isophthalic Acid

Isophthalic Acid

SCHEMBL4450605

O=C([O-])c1cccc(C(=O)[O-])c1.O=C([O-])c1cccc(C(=O)[O-])c1.O=C([O-])c1cccc(C(=O)[O-])c1.[Fe+3].[Fe+3]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 11/20 0.59
▸ CA4 P22748 1/20 0.59
▸ ATM Q13315 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ USP2 O75604 1/20 0.45
▸ CA1 P00915 10/20 0.44
▸ CES2 O00748 2/20 0.41
▸ CES1 P23141 2/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA6 P23280 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isophthalic Acid SCHEMBL9690980 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1
Isophthalic Acid SCHEMBL3679236 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1
Isophthalic Acid SCHEMBL848177 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1
Isophthalic Acid SCHEMBL23035004 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1
Isophthalic Acid SCHEMBL11292195 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1
Isophthalic Acid SCHEMBL23035003 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1
Isophthalic Acid SCHEMBL8621378 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1
Isophthalic Acid SCHEMBL25202017 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1
Isophthalic Acid SCHEMBL9690976 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1
Isophthalic Acid SCHEMBL7566222 0.94 CA2 (0.59) CA2CA4ATMTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119133448-A Iron isophthalate negative electrode material for lithium battery and preparation method thereof 成都理工大学 2024-12-13 — — CN claimed
CN-115232011-B Method for synthesizing p-nitrobenzoic acid 浙江乾精新材料科技有限责任公司 2023-11-24 — — CN claimed
CN-115624988-A Organic iron-SiO 2 Type aerogel catalyst and preparation method thereof 贵州大学 2023-01-20 — — CN claimed
CN-115232011-A Method for synthesizing p-nitrobenzoic acid 浙江乾精新材料科技有限责任公司 2022-10-25 — — CN claimed
CN-114085580-A Water-based metal baking paint and preparation method thereof 江苏中瀛涂料有限公司 2022-02-25 — — CN claimed
JP-56161349-A — — None — — JP disclosed
CN-119133448-A Iron isophthalate negative electrode material for lithium battery and preparation method thereof 成都理工大学 2024-12-13 — — CN disclosed
CN-119133448-A Iron isophthalate negative electrode material for lithium battery and preparation method thereof 成都理工大学 2024-12-13 — — CN disclosed
CN-115232011-B Method for synthesizing p-nitrobenzoic acid 浙江乾精新材料科技有限责任公司 2023-11-24 — — CN disclosed
CN-115624988-A Organic iron-SiO 2 Type aerogel catalyst and preparation method thereof 贵州大学 2023-01-20 — — CN disclosed
CN-114085580-A Water-based metal baking paint and preparation method thereof 江苏中瀛涂料有限公司 2022-02-25 — — CN disclosed
CN-112351697-A Evaporator device with material box 尤尔实验室有限公司 2021-02-09 — — CN disclosed
EP-2015647-A2 IRON COMPLEX FOR USE IN THE TREATMENT AND/OR PREVENTION OF NUTRITIONAL DISORDERS UNILEVER N.V. (NL) 2009-01-21 — — EP disclosed
WO-2006037449-A2 IRON COMPLEX FOR USE IN THE TREATMENT AND/OR PREVENTION OF NUTRITIONAL DISORDERS UNILEVER N.V. (NL) 2006-04-13 — — WO disclosed
US-20060078594-A1 Iron complex CONOPCO, INC., D/B/A UNILEVER 2006-04-13 — — US disclosed
JP-S56161349-A PREPARATION OF 2-HYDROXYALKYL ACRYLATE OR 2-HYDROXYALKYL METHACRYLATE NIPPON SHOKUBAI KAGAKU KOGYO CO LTD 1981-12-11 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060078594-A1 Iron complex SLC40A1, FECH, TFRC CA2 1969/4885CA4 2594/4885ATM 3584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback